Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SOXS | 37.19 | 2.80 | +8.14% |
| Direxion Daily Semiconductor Bear 3X ETF (SOXS) | |||
| NRES | 34.34 | 0.16 | +0.46% |
| Xtrackers Rreef Global Natural Resources ETF (NRES) | |||
| FEUS | 84.97 | 0.14 | +0.17% |
| Northern Trust ESG & Climate US Large Cap Core ETF (FEUS) | |||
| BAPR | 55.10 | N/A | N/A |
| Innovator U.S. Equity Buffer ETF - April (BAPR) | |||
| EVMT | 17.22 | -0.01 | -0.03% |
| Invesco Electric Vehicle Metals Commodity Strategy No K-1 ETF (EVMT) | |||
A.I.dvisor indicates that over the last year, STXS has been loosely correlated with SMTI. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if STXS jumps, then SMTI could also see price increases.
| Ticker / NAME | Correlation To STXS | 1D Price Change % | ||
|---|---|---|---|---|
| STXS | 100% | +2.70% | ||
| SMTI - STXS | 38% Loosely correlated | +0.23% | ||
| TWST - STXS | 36% Loosely correlated | -4.96% | ||
| CERS - STXS | 35% Loosely correlated | -1.74% | ||
| BLFS - STXS | 35% Loosely correlated | N/A | ||
| VCYT - STXS | 33% Poorly correlated | -2.68% | ||
More | ||||
| Ticker / NAME | Correlation To STXS | 1D Price Change % |
|---|---|---|
| STXS | 100% | +2.70% |
| Pharmaceuticals: Other industry (50 stocks) | -7% Poorly correlated | +0.04% |
| Pharmaceuticals industry (154 stocks) | -13% Poorly correlated | -1.31% |
a designer of robotic cardiology instrument navigation systems
Industry PharmaceuticalsOther
The Aroon Indicator for STXS entered a downward trend on October 12, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 231 similar instances where the Aroon Indicator formed such a pattern. In 204 of the 231 cases the stock moved lower. This puts the odds of a downward move at 88%.
The Momentum Indicator moved below the 0 level on September 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on STXS as a result. In 86 of 105 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The Moving Average Convergence Divergence Histogram (MACD) for STXS turned negative on September 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 39 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
STXS moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where STXS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where STXS's RSI Indicator exited the oversold zone, 21 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 72%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +5.26% 3-day Advance, the price is estimated to grow further. Considering data from situations where STXS advanced for three days, in 162 of 211 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
STXS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 45 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 87 (best 1 - 100 worst), indicating slightly worse than average price growth. STXS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.309) is normal, around the industry mean (5.011). P/E Ratio (57.970) is within average values for comparable stocks, (163.451). Projected Growth (PEG Ratio) (12.600) is also within normal values, averaging (4.456). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (4.248) is also within normal values, averaging (56.074).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STXS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.